NIH Award Supports VBRI Research into Lipoprotein(a) and Cardiovascular Risk

November 19, 2026

 

Treatments that lower cholesterol help address cardiovascular risk, but they don’t answer every question about why people develop heart disease.

Dr. Ze Zheng, Investigator at Versiti Blood Research Institute

Dr. Ze Zheng, an investigator at Versiti Blood Research Institute (VBRI) and associate professor of medicine and associate director of basic science research at the Medical College of Wisconsin (MCW), is investigating another part of that picture: lipoprotein(a), or Lp(a), a particle in the blood linked to cardiovascular disease. 

A new National Institutes of Health R01 award will support Zheng’s team as it works to understand how the body regulates Lp(a). The research could help lay the groundwork for future approaches to addressing cardiovascular risk. 

Looking more closely at Lp(a)

Genetics strongly influence a person’s Lp(a) levels. But researchers still have questions about the biological processes that control how the particle forms and how much circulates in the blood. 

The National Heart, Lung, and Blood Institute funds the project, “The role of tPA in reducing Lp(a) assembly.” Zheng is collaborating with Columbia University investigator Gissette Reyes-Soffer on the research, which runs through March 2030. 

The goal is to better understand how Lp(a) is regulated and what that could mean for cardiovascular risk. 

Bringing expertise together

Studying Lp(a) presents technical challenges. Researchers need specialized tools and approaches to investigate its biology and test their questions. 

Based at VBRI, Zheng's laboratory draws on specialized equipment, technology, and scientific expertise to investigate the biological processes involved in Lp(a) regulation. The work reflects the institute's commitment to advancing scientific understanding of blood health and exploring questions with potential implications for human health. 

The new award builds on Zheng’s broader research into the connections between lipid biology and the body’s systems for forming and breaking down blood clots. 

Through this work, Zheng and her collaborators aim to deepen scientific understanding of Lp(a) and its connections to cardiovascular health.